Gridelli, Cesare

Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer

Camidge, D. R., Kim, H. R., Ahn, M.-J., Yang, J. C.-H., Han, J.-Y., Lee, J.-S., Hochmair, M. J., Li, J. Y.-C., Chang, G.-C., Lee, K. H., et al. (2018) · New England Journal of Medicine

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 980

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

Di Maio, M., Gallo, C., Leighl, N. B., Piccirillo, M. C., Daniele, G., Nuzzo, F., Gridelli, C., Gebbia, V., Ciardiello, F., De Placido, S., et al. (2015) · Journal of Clinical Oncology

Cancer survivorship and carePharmacovigilance and Adverse Drug Reactions

Cited by 497

Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer

Di Maio, M., Chiodini, P., Georgoulias, V., Hatzidaki, D., Takeda, K., Wachters, F. M., Gebbia, V., Smit, E. F., Morabito, A., Gallo, C., et al. (2009) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 181

The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer

Gridelli, C., Rossi, A., & Maione, P. (2008) · Critical Reviews in Oncology/Hematology

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation

Cited by 54

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

Gargiulo, P., Arenare, L., Gridelli, C., Morabito, A., Ciardiello, F., Gebbia, V., Maione, P., Spagnuolo, A., Palumbo, G., Esposito, G., et al. (2021) · BMC Cancer

Lung Cancer Diagnosis and TreatmentInflammatory Biomarkers in Disease Prognosis

Cited by 22